Cargando…
Pan-cancer application of a lung-adenocarcinoma-derived gene-expression-based prognostic predictor
Gene-expression profiling can be used to classify human tumors into molecular subtypes or risk groups, representing potential future clinical tools for treatment prediction and prognostication. However, it is less well-known how prognostic gene signatures derived in one malignancy perform in a pan-c...
Autores principales: | Nacer, Deborah F, Liljedahl, Helena, Karlsson, Anna, Lindgren, David, Staaf, Johan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8574611/ https://www.ncbi.nlm.nih.gov/pubmed/33971670 http://dx.doi.org/10.1093/bib/bbab154 |
Ejemplares similares
-
Consensus of gene expression phenotypes and prognostic risk predictors in primary lung adenocarcinoma
por: Ringnér, Markus, et al.
Publicado: (2016) -
A gene expression‐based single sample predictor of lung adenocarcinoma molecular subtype and prognosis
por: Liljedahl, Helena, et al.
Publicado: (2020) -
Performance of gene expression–based single sample predictors for assessment of clinicopathological subgroups and molecular subtypes in cancers: a case comparison study in non-small cell lung cancer
por: Cirenajwis, Helena, et al.
Publicado: (2019) -
Relation between smoking history and gene expression profiles in lung adenocarcinomas
por: Staaf, Johan, et al.
Publicado: (2012) -
Perturbation and stability of PAM50 subtyping in population-based primary invasive breast cancer
por: Veerla, Srinivas, et al.
Publicado: (2023)